| Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions LL Anderson, NL Absalom, SV Abelev, IK Low, PT Doohan, LJ Martin, ... Epilepsia 60 (11), 2224-2234, 2019 | 126 | 2019 |
| Access to cannabidiol without a prescription: a cross-country comparison and analysis IS McGregor, EA Cairns, S Abelev, R Cohen, M Henderson, D Couch, ... International Journal of Drug Policy 85, 102935, 2020 | 82 | 2020 |
| Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20) N Lintzeris, L Mills, SV Abelev, A Suraev, JC Arnold, IS McGregor Harm reduction journal 19 (1), 88, 2022 | 25 | 2022 |
| Medicinal cannabis for inflammatory bowel disease: a survey of perspectives, experiences, and current use in Australian patients MJ Benson, SV Abelev, SJ Connor, CJ Corte, LJ Martin, LK Gold, ... Crohn's & Colitis 360 2 (2), otaa015, 2020 | 23 | 2020 |
| Genetic deletion of P-glycoprotein alters stress responsivity and increases depression-like behavior, social withdrawal and microglial activation in the hippocampus of female mice NI Brzozowska, KL Smith, C Zhou, PM Waters, LM Cavalcante, SV Abelev, ... Brain, behavior, and immunity 65, 251-261, 2017 | 23 | 2017 |
| Medicinal cannabis for the treatment of chronic refractory pain: an investigation of the adverse event profile and health-related quality of life impact of an oral formulation S Abelev, LN Warne, M Benson, M Hardy, S Nayee, J Barlow Medical Cannabis and Cannabinoids 5 (1), 20-31, 2022 | 15 | 2022 |
| Attitudes and knowledge of Australian gastroenterologists around the use of medicinal cannabis for inflammatory bowel disease MJ Benson, SV Abelev, CJ Corte, SJ Connor, IS McGregor Crohn's & Colitis 360 2 (2), otaa045, 2020 | 8 | 2020 |
| The effectiveness and adverse events of cannabidiol and tetrahydrocannabinol used in the treatment of anxiety disorders in a PTSD subpopulation: An interim analysis of an … SK Stack, NJ Wheate, NC Moloney, SV Abelev, JW Barlow, EA Schubert Journal of Pharmacy Technology 39 (4), 172-182, 2023 | 5 | 2023 |
| Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey A Suraev, L Mills, SV Abelev, TR Arkell, N Lintzeris, IS McGregor Nature and Science of Sleep, 245-255, 2023 | 2 | 2023 |
| Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey TR Arkell, SV Abelev, L Mills, A Suraev, JC Arnold, N Lintzeris, ... Journal of cannabis research 5 (1), 35, 2023 | 2 | 2023 |
| Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022 (CAMS-22) L MILLS, JC ARNOLD, A SURAEV, SV ABELEV, C ZHOU, TR ARKELL, ... | | 2024 |
| How Australians' medical cannabis use has changed since deregulation: Results from the Cannabis As Medicine Surveys L Mills, J Arnold, A Suraev, SV Abelev, C Zhou, TR Arkell, IS McGregor, ... DRUG AND ALCOHOL REVIEW 42, S120-S120, 2023 | | 2023 |
| Genetic deletion of P-glycoprotein alters stress responsivity and increases depression-like behavior, social withdrawal and microglial activation in the hippocampus of female mice S Abelev, J Arnold, N Brzozowska, D Clarke, M Kuligowski, ... Academic Press, 2017 | | 2017 |
